Higher, But Cautious | GenomeWeb

Higher, But Cautious

Biotech stocks are climbing high, but Reuters' Deena Beasley writes that a nearly 50 percent increase in the last year has stoked worries about a bubble. She notes that the Nasdaq Biotech Index is up 45 percent as compared to last year and the Pharmaceutical Index is similarly up 32 percent, while during the same timeframe, the S&P 500 Index gained 25 percent.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

In Nature this week: genetic link between birth weight and adult-onset diseases, and more.

Even with all the current enthusiasm for gene therapies, Tech Review cautions that they are mostly in the early stages of development.

DNA phenotyping puts a potential face to a suspect in a nearly 25-year-old murder, the AP reports.

Researchers discuss the need for antibody standards at a meeting, NPR reports.